Advertisement

Response of Fetal Tissue to Wounding

  • Timothy M. Crombleholme

Abstract

Until the advent of obstetrical ultrasound, the womb shielded the fetus from both observation and intervention. This technology has made possible the prenatal diagnosis of a broad range of structural anomalies and the definition of their natural history, as well as offering the opportunity for fetal surgical intervention.1 As a result an empiric observation was make from clinical fetal surgery that the midgestation human fetus heals without scarring.2 This confirmed a previous observation by Rowlatt3 that the human fetus heals by mesenchymal regeneration without scar formation. These observations sparked experimental studies in fetal wound healing in animal models ranging from rats to rhesus monkeys, which consistently demonstrated distinct differences between fetal and adult wound healing.4 Although the fundamental nature of these differences remains ill-defined, factors in three areas are likely to contribute to them, including differences in the fetal environment, fetal cells, and the fetal extracellular matrix.5

Keywords

Hyaluronic Acid Fetal Tissue Incisional Wound Fetal Fibroblast Fetal Skin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Crombleholme TM. Invasive fetal therapy: current status and future directions. Semin Perinat. 1994; 18 (4): 385–397.Google Scholar
  2. 2.
    Harrison MR. Personal communication.Google Scholar
  3. 3.
    Rowlatt V. Intrauterine wound healing in a 20-week gestation fetus. Virchows Arch. 1979; 381: 353–355.Google Scholar
  4. 4.
    Adzick NS, Longaker MT, eds. Fetal Wound Healing. New York: Elsevier Scientific; 1992.Google Scholar
  5. 5.
    Lorenz HP, Adzick NS. Scarless skin wound repair in the fetus. West J Med. 1993; 159; 350–355.PubMedGoogle Scholar
  6. 6.
    Nelson NM. Respiration and circulatory changes before birth. In: Smith CA, Nelson NM, eds. The Physiology of the Newborn Infant. 4th ed. Springfield, MA: Charles C. Thomas; 1976: 75–121.Google Scholar
  7. 7.
    Decker M, Chiu ES, Dollbaum C, et al. Hyaluronic acid-stimulating activity in sera from the bovine fetus and from breast cancer patients. Cancer Res. 1989; 49: 3499–3505.PubMedGoogle Scholar
  8. 8.
    Estes JM, Spenser EM, Longaker MT, Adzick NS. Insulin-like growth factor-II in ovine wound fluid: evidence for developmental regulation. Surg Forum. 1991; 42: 659–661.Google Scholar
  9. 9.
    Longaker MT, Whitby DJ, Jennings RW, et al. Adult skin in the fetal environment heals with scar formation. Surg Forum. 1990; 41: 639–641.Google Scholar
  10. 10.
    Crombleholme TM, Langer JC, Harrison MR, et al. Transplantation of fetal cells. Am J Obstet Gynecol. 1991; 164: 218–230.PubMedGoogle Scholar
  11. 11.
    Lorenz HP, Longaker MT, Perkocha LA, Jennings RW, Harrison MR, Adzick NS. Scarless wound repair: a human fetal skin model. Development. 1992; 114: 253–259.PubMedGoogle Scholar
  12. 12.
    Lorenz HP, Longaker MT, Whitby DJ, Harrison MR, Adzick NS. Scarless fetal skin repair is intrinsic to the fetal fibroblast. Surg Forum. 1992; 43: 694–696.Google Scholar
  13. 13.
    Longaker MT, Whitby DJ, Adzick NS, et al. Studies in fetal wound healing-VI. Second and early third trimester fetal wounds demonstrate rapid collagen deposition without scar formation. J Pediatr Surg. 1990; 25: 63–69.PubMedCrossRefGoogle Scholar
  14. 14.
    Whitby DJ, Ferguson MWJ. The extracellular matrix of lip wounds in fetal, neonatal and adult mice. Development. 1991; 112: 651–668.PubMedGoogle Scholar
  15. 15.
    Mast BA, Krummel TM. Acute inflammation in fetal wound healing. In: Adzick NS, Longaker MT, eds. Fetal Wound Healing. New York: Elsevier Scientific; 1992: 227–240.Google Scholar
  16. 16.
    Adzick NS, Harrison MR, Glick PL, et al. Comparison of fetal, newborn, and adult wound healing by histologic, enzyme-histochemical, and hydroxyproline determinations. J Pediatr Surg. 1985; 20: 315–319.PubMedCrossRefGoogle Scholar
  17. 17.
    Longaker MT, Bouhana KS, Roberts AB, Harrison MR, Adzick NS, Banda MJ. Regulation of fetal wound healing. Surg Forum. 1991; 42: 575–577.Google Scholar
  18. 18.
    Moriarty KP, Crombleholme TM, Gallivan EK, et al. Hyaluronic acid-dependent pericellular matrices in fetal fibroblasts: implications for scar-free wound repair. Wound Repair Reg. 1996: 4: 346–352.CrossRefGoogle Scholar
  19. 19.
    Toole BP. Glycosaminoglycans in morphogenesis. In: Hay ED, ed. Cell Biology of the Extracellular Matrix. New York: Plenum Press; 1982: 259–294.Google Scholar
  20. 20.
    Adzick NS, Longaker MT. Scarless fetal healing: therapeutic implications. Ann Surg. 1992; 215: 3–12.PubMedCrossRefGoogle Scholar
  21. 21.
    Adolph VR, Bleacher JC, Dillon PW, et al. The role of hyaluronidase activity on extracellular matrix composition in fetal wounds. Surg Forum. 1992; 43: 702–704.Google Scholar
  22. 22.
    Longaker MT, Chiu ES, Adzick NS, Stern M, Harrison MR. Studies in fetal wound healing: V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid. Ann Surg. 1991; 213: 292–296.PubMedCrossRefGoogle Scholar
  23. 23.
    Mast BA, Haynes JH, Krummel TM, et al. In vivo degradation of fetal wound hyaluronic acid results in increased fibroplasia, collagen deposition, and neovascularization. Plast Reconstr Surg. 1992; 89: 503–510.PubMedCrossRefGoogle Scholar
  24. 24.
    Knudson CP, Toole BP. Changes in pericellular matrix during differentiation of limb bud mesoderm. Dev Biol. 1985; 112: 305–318.CrossRefGoogle Scholar
  25. 25.
    Toole BP, Banerjie SD, Turner R, et al. Hyaluronan interactions in limb bud development. In: Hinchcliffe JR, Hurle J, Summkell D, eds. Developmental Patterning of the Vertebrate Limb. New York: Plenum; 1991; 215–223.CrossRefGoogle Scholar
  26. 26.
    Clarins BJ, Fraser JRE. On the pericellular zone of same mammalian cells in vitro. Exp Cell Res. 1968; 49: 181–193.CrossRefGoogle Scholar
  27. 27.
    McGuire PG, Castello JJ, Orkin RW. Size-dependent hyaluronate degradation by cultured cells. J Cell Physiol. 1987; 133: 267–276.PubMedCrossRefGoogle Scholar
  28. 28.
    Yu Q, Banejie SD, Toole BP. Loss of hyaluronate-dependent coat during myoblast fusion. Dev Biol. 1985; 107: 527–530.CrossRefGoogle Scholar
  29. 29.
    Goldberg RL, Toole BP. Pericellular coat of chick embryo chondrocytes: structural role of hyaluronate. J Biol Chem. 1984; 99: 2114–2122.Google Scholar
  30. 30.
    Hardwick C, Hoore K, Owens R, et al. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol. 1992; 117: 1343–1350.PubMedCrossRefGoogle Scholar
  31. 31.
    Toole BP, Turner RE, Banerjie SD. Hyaluronan binding protein in chondrogenesis and angiogenesis. In: The Developing Limb in Limb Development and Regeneration. New York: Wiley-Liss; 1993; 437–444.Google Scholar
  32. 32.
    Ruoslahte E, Yamaguchi Y, Hildebrand A, et al. Extracellular matrix/growth factor interactions. Cold Spring Harb Symp Quant Biol. 1992; 57: 309–315.CrossRefGoogle Scholar
  33. 33.
    Chen WYJ, Grant MF, Schor AM, et al. Differences between adult and fetal fibroblasts in the regulation of hyaluronate synthesis: correlation with migratory activity. J Cell Sci. 1989; 94: 577–584.PubMedGoogle Scholar
  34. 34.
    Schor SL, Schor AM, Grey AM, et al. Fetal and cancer patient fibroblasts produce an autocrine migration stimulating factor not made by normal adult cells. J Cell Sci. 1988; 90: 391–399.PubMedGoogle Scholar
  35. 34.
    Schor SL, Schor AM, Grey AM, et al. Fetal and cancer patient fibroblasts produce an autocrine migration stimulating factor not made by normal adult cells. J Cell Sci. 1988; 90: 391–399.PubMedGoogle Scholar
  36. 36.
    Turley EA, Austen L, Vandeligt K, Clary C. Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ros-transformed cells. J Cell Biol. 1991; 112 (1): 1041–1047.PubMedCrossRefGoogle Scholar
  37. 37.
    Crombleholme TM. Unpublished data.Google Scholar
  38. 38.
    Estes JM, VandeBerg JS, Adzick NS, et al. Phenotypic and functional features of myofibroblasts in sheep fetal wounds. Differentiation. 1994; 56: 173–181.PubMedCrossRefGoogle Scholar
  39. 39.
    Nakono S, Ts’O PO. Cellular differentiation and neoplasia: characterization of sub-populations of cells that have neoplasia-related growth properties in Syrian hamster embryo cell cultures. Proc Natl Acad Sci USA. 1982; 78: 4995–4999.CrossRefGoogle Scholar
  40. 40.
    Clemmons DR. Age-dependent production of a competence factor by human fibroblasts. J Cell Physiol. 1983; 114: 61–67.PubMedCrossRefGoogle Scholar
  41. 41.
    Lawrence DA, Pircher CKM, Jullien P. Normal embryo fibroblasts release transforming growth factor in latent form. J Cell Physiol. 1984; 121: 184–188.PubMedCrossRefGoogle Scholar
  42. 42.
    Eisinger M, Marko O, Ogata SI, Old LJ. Growth regulation of human melanocytes: mitogenic factors in extracts of melanoma, astrocytoma and fibroblast lines. Science. 1985; 229: 984–986.PubMedCrossRefGoogle Scholar
  43. 43.
    Hill DJ, Strain AJ, Elstow SF, Swine I, Milner RD. Bifunctional action of transforming growth factor-beta on DNA synthesis in early passage human fetal fibroblasts. J Cell Physiol. 1986; 128: 322–328.PubMedCrossRefGoogle Scholar
  44. 44.
    Moriarty KP, Crombleholme TM. Differential fibroblast chemotaxis in fetal, neonatal, and adult cell lines in response to TGF-β1 and fetal bovine serum. Surg Forum. 1995; 46: 679–681.Google Scholar
  45. 45.
    Schor SL, Schor AM, Rushton G, Smith L. Adult, foetal, and transformed fibroblasts display different migratory phenotypes on collagen gels: evidence for an isoformic transition during fetal development. J Cell Sci. 1985; 73: 221–234.PubMedGoogle Scholar
  46. 46.
    Motsura H, Hakomori SF. The oncofetal domain of fibronectin defined by a monoclonal antibody FDC-6: its presence in fetal and tumor tissues and its absence in those from normal tissue and plasma. Proc Natl Acad Sci USA. 1985; 83: 6517–6521.CrossRefGoogle Scholar
  47. 47.
    Castellini P, Siri A, Rosellini C, et al. Transformed cells release different fibronectin variants than do normal cells. J Cell Biol. 1986; 103: 1671–1678.CrossRefGoogle Scholar
  48. 48.
    Bartal AH, Lichtig C, Cordon-Cardo C, et al. Monoclonal antibody defining fibroblasts appearing in fetal and neoplastic tissues. J Natl Cancer Inst. 1986; 76: 415–419.PubMedGoogle Scholar
  49. 49.
    Longaker MT, Harrison MR, Crombleholme TM, et al. Studies in fetal wound healing I. A factor in fetal serum that stimulates deposition of hyaluronic acid. J Pediatr Surg. 1989; 24: 789–792.PubMedCrossRefGoogle Scholar
  50. 50.
    Longaker MT, Chiu ES, Harrison MR, et al. Studies in fetal wound healing IV. Hyaluronic acid-stimulating activity distinguishes fetal from adult wound fluid. Ann Surg. 1989; 210: 667–672.PubMedCrossRefGoogle Scholar
  51. 51.
    Longaker MT, Adzick NS, Hall JL, et al. Studies in fetal wound healing: VII. Fetal wound healing may be modulated by hyaluronic acid stimulating activity in amniotic fluid. J Pediatr Surg. 1990; 25: 430–433.PubMedCrossRefGoogle Scholar
  52. 52.
    Burd DAR, Longaker MT, Adzick NS, et al. Fetal wound healing: an in vitro explant model. J Pediatr Surg. 1990; 25: 898–901.PubMedCrossRefGoogle Scholar
  53. 53.
    Riva-Lacert MP, Casasin T, Pumarola F, et al. An alternative treatment for the reduction of tympanic membrane perforations: sodium hyaluronate. Acta Otolaryngol (Stockh). 1990; 110: 110–114.CrossRefGoogle Scholar
  54. 54.
    Lorenz HP, Whitby DJ, Longaker MT, Adzick NS. The ontogeny of scar formation in the non-human primate. Ann Surg. 1993; 217: 391–396.PubMedCrossRefGoogle Scholar
  55. 55.
    Smith LT, Holbrook KA, Madri JA. Collagen types I, III and V in human embryonic and fetal skin. Am J Anat. 1986; 175: 507–521.PubMedCrossRefGoogle Scholar
  56. 56.
    Scott JE, Hughes EW. Proteoglycan risk relationships in developing chick and bovine tendons: influence of the physiologic environment. Connect tissue Res. 1986; 14: 267–278.PubMedCrossRefGoogle Scholar
  57. 57.
    Burd DAR, Longaker MT, Adzick NS, Harrison MR, Ehrlich HP. Fetal wound healing in a large animal model: the deposition of collagen is confirmed. Br J Plast Surg. 1990; 43: 571–577.PubMedCrossRefGoogle Scholar
  58. 58.
    Longaker MT, Whitby DJ, Ferguson MEW, et al. Studies in fetal wound healing: III. Early deposition of fibronectin distinguishes fetal from adult wound healing. J Pediatr Surg. 1989; 24: 799–805.PubMedCrossRefGoogle Scholar
  59. 59.
    Whitby DJ, Longaker MT, Harrison MR, Adzick NS, Ferguson MW. Rapid epithelialisation of fetal wound is associated with early deposition of tenascin. J Cell Sci. 1991; 99: 583–586.PubMedGoogle Scholar
  60. 60.
    Pierce SF, Brown D, Mustoe TA. Quantitative analysis of inflammatory cell efflux, procollagen type I synthesis, and collagen cross-linking in incisional wounds. Influence of PDGF and TGF-β1 therapy. J Lab Clin Med. 1991; 117: 373–382.PubMedGoogle Scholar
  61. 61.
    Dumm SK, Oppenheim J.T. Macrophage-derived mediators: interleukin 1, tumor necrosis factor, interleukin 6, interferon, and related cytokines. In: Paul WE, ed. Fundamental Immunology. 2nd ed. New York: Raven Press; 1989; 639–661.Google Scholar
  62. 62.
    Barnard JA, Lyons RM, Moses HL. The cell biology of transforming growth factor-beta. Biochem Biophys Acta. 1990; 1032: 79–87.PubMedGoogle Scholar
  63. 63.
    Adzick NS, Lorenz HP. Cells, matrix, growth factors, and the surgeon. The biology of scarless fetal wound repair. Ann Surg. 1994; 220: 10–18.PubMedCrossRefGoogle Scholar
  64. 64.
    Ferguson MWJ, Howarth GF. Marsupial models of scarless fetal wound healing. In: Adzick NS, Longaker MT, eds. Fetal Wound Healing. New York: Elsevier Science Press; 1991.Google Scholar
  65. 65.
    Castilla A, Prieto J, Fausto N. Transforming growth factor beta 1 and alpha in chronic liver disease: effects of interferon alpha therapy. N Engl J Med. 1991; 324: 933–940.PubMedCrossRefGoogle Scholar
  66. 66.
    Braekelmann TJ, Limper AH, Colby TV, et al. Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA. 1991; 88: 6642–6646.CrossRefGoogle Scholar
  67. 67.
    Border WA, Okuda S, Languino, et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature. 1990; 346: 371–374.PubMedCrossRefGoogle Scholar
  68. 68.
    Border WA, Noble NA, Yamamoto T, et al. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature. 1992; 360: 361–364.PubMedCrossRefGoogle Scholar
  69. 69.
    Peltonen J, Kahari L, Jaakkola S, et al. Evaluation of transforming growth factor-β and type I procollagen gene expression in fibrotic diseases by in situ hybridization. J Invest Dermatol. 1990; 94: 365–371.PubMedCrossRefGoogle Scholar
  70. 70.
    Krummel TM, Michna BA, Thomas BL, et al. TGF-β induces fibrosis in a fetal wound model. J Pediatr Surg. 1988; 23: 647–652.PubMedCrossRefGoogle Scholar
  71. 71.
    Sullivan KM, Lorenz HP, Adzick NS. The role of transforming growth factors β1 and β2 synergistically wound healing. Surg Forum. 1993; 44: 625–627.Google Scholar
  72. 72.
    Lorenz HP, Chang J, Longaker MT, Banda MJ. Transforming growth factors β1 and β2 synergistically increase collagen gene expression in fetal fibroblasts but not in adult fibroblasts. Surg Forum. 1993; 44: 723–725.Google Scholar
  73. 73.
    Shah M, Roberts AB, Gold LI, Ferguson MWJ. Immunolocalization of TGF-ß isoforms in normal and experimentally modulated incisional wounds in adult rodents. Wound Rep Reg. 1993; 2: 124.Google Scholar
  74. 74.
    Siebert JW, Sung JJ, Zirn J, et al. Immunohistochemical localization of TGF-β1 and β3 isoforms during fetal wound healing. Surg Forum. 1995; 46: 646–648.Google Scholar
  75. 75.
    Moriarty KP, Crombleholme TM, Alman B, Garmel S. Absence of PDGF-receptor up regulation in fetal wounds. Poster presentation at the 26th Annual American Pediatrics Surgical Association, Boca Raton, Florida May 22, 1995.Google Scholar
  76. 76.
    Antonaides HN. Human platelet derived growth factor (PDGF): purification of PDGF-1 and PDGF-II and separation of their reduced subunits. Proc Natl Acad Sci. 1981; 78: 7314–7317.CrossRefGoogle Scholar
  77. 77.
    Devel TF, Senior RM, Chang D, et al. Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci USA. 1991; 78: 4584–4587.Google Scholar
  78. 78.
    Raines EW, Ross R. Platelet derived growth factor-I: High yield purification and evidence for multiple form. J Biol Chem. 1982; 257: 5154–5160.PubMedGoogle Scholar
  79. 79.
    Devel TF, Huang JS. Platelet-derived growth factor: structure function and roles in normal and transformed cells. J Clin Invest. 1984; 74: 669–676.CrossRefGoogle Scholar
  80. 80.
    Devel TF, Senior RM, Huang JS, et al. Chemotaxis of monocytes and neutrophils to platelet derived growth factor. J Clin Invest. 1982; 69: 1046–1049.CrossRefGoogle Scholar
  81. 81.
    Haynes JH, Johnson DE, Flood LC, et al. Platelet derived growth factor induces fibrosis at a fetal wound site. Surg Forum. 1990; 41: 641–643.Google Scholar
  82. 82.
    Gospodorowicz D. Localization of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature. 1974; 249: 123–127.CrossRefGoogle Scholar
  83. 83.
    Gospodorowicz D, Bialecki H. The effects of epidermal and fibroblast growth factors on the replicative lifespan of cultured bovine granulosa cells. Endocrinology. 1978; 103: 854–858.CrossRefGoogle Scholar
  84. 84.
    Faustanier A, Courtly J, Muller E, et al. Edge-derived growth factor isolated from bovine retina and used for epidermal wound healing in vivo. J Invest Dermatol. 1986; 8: 76–80.Google Scholar
  85. 85.
    Bientrick P, Jentzsch KD, Heder G. Stimulation of wound healing using brain extract with fibroblast growth factor (FGF) activity. I. Quantitative and biochemical studies into formation of granulation tissue. Exp Pathol. 1982; 21: 46–53.CrossRefGoogle Scholar
  86. 86.
    Gallivan EK, Crombleholme TM, O’Donnell C, et al. Induction of fetal pattern of migration in postnatal fibroblasts of TGF-β3. Presented at the Society for University Surgeons, Washington, D.C., February 8, 1996.Google Scholar
  87. 87.
    Shah M, Foreman DM, Ferguson MW. Control of scarring in adult wounds by neutralizing antibody to transforming growth factor-beta. Lancet. 1992; 339: 213–214.PubMedCrossRefGoogle Scholar
  88. 88.
    Longaker MT, Whitby DJ, Jennings RW, et al. Fetal diaphragmatic wounds heal with scar formation. J Surg Res. 1991; 50: 375–385.PubMedCrossRefGoogle Scholar
  89. 89.
    Meuli M, Lorenz HP, Hedrick MH, et al. Scar formation in the fetal alimentary tract. J Pediatr Surg. 1995; 30: 392–395.PubMedCrossRefGoogle Scholar
  90. 90.
    Longaker MT, Moelleken BRW, Cheng JC, et al. Fetal fracture healing in a lamb model. Plast Reconstr Surg. 1992; 90: 161–171.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Timothy M. Crombleholme

There are no affiliations available

Personalised recommendations